the metoprolol atherosclerosis prevention in hypertension trial , an extension of the happhy trial , showed that smokers receiving the beta blocker metoprolol had a significantly lower cardiovascular mortality rate than those randomized to a diuretic drug .
C0003850
atherosclerosis
C0007226
cardiovascular